This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Company. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: The Innovations of Michael W. Lovell
Introduction
Michael W. Lovell is a notable inventor based in Syracuse, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic compounds. His work has led to advancements that are beneficial in medical applications.
Latest Patents
Michael W. Lovell holds a patent for a process titled "3-Propenzl cephalosporin isomer separation process and derivative." This patent involves the antibiotic 7-[D-2-amino-2-(4-hydroxyphenyl)acetamido]-3-[(Z)-1-propenyl]ceph-3-em-4-carboxylic acid (BMY-28100). The process details how this antibiotic forms imidazolidinone derivatives when reacted with ketones. These derivatives are crucial for pharmaceutical dosage forms and serve as intermediates for separating them from mixtures containing the [(E)-1-propenyl] isomer of the antibiotic. Michael has 1 patent to his name.
Career Highlights
Throughout his career, Michael has been associated with Bristol-Myers Company, where he has contributed to various innovative projects. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.
Collaborations
Michael has worked alongside notable colleagues such as Joseph B. Bogardus and Murray A. Kaplan. Their collaborative efforts have further enhanced the research and development of pharmaceutical products.
Conclusion
Michael W. Lovell's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile